23 December,2022 12:46 PM IST | New Delhi | mid-day online correspondent
Representative image
The Union Health Ministry has given approval to Bharat Biotech's intranasal Covid vaccine for inclusion in the vaccination programme as a booster dose for those above 18 years of age, official sources said. The needle-free vaccine will be available at private vaccination centres.
The approval for the vaccine comes amid a spurt in Covid cases in China and some other countries. "The needle-free vaccine will be introduced on the Co-WIN platform on Friday evening," they said.
Also read: Maharashtra: Time to mask up in crowded places, says Health minister
The nasal vaccine -- BBV154 -- received approval of the Drugs Controller General of India in November for restricted use in an emergency situation for those above 18 as a heterologous booster dose.
ALSO READ
Ensure safety of minorities: India on arrest of Hindu leader Chinmoy Das in Bangladesh
13 British healthcare companies take part in 10th UK-India Healthcare Trade Mission
HC seeks Centre's response on questions regarding Rahul Gandhi's citizenship
Rahul, Priyanka to lead agitation against Centre's 'neglect' of Wayanad
Jaishankar meets Blinken in Italy, discusses state of world, India-US partnership
(with inputs from PTI)